EU EFSA Health Claims: How Chinese Supplement Manufacturers Can Stay Compliant and Avoid Costly Mistakes

Selling dietary supplements in the European Union is a massive opportunity — but it comes with one of the world’s most stringent regulatory frameworks. The European Food Safety Authority (EFSA) governs health claims on food and supplement products through Regulation (EC) No 1924/2006, and the rules are very different from what most Chinese manufacturers are familiar with.

If you are a Chinese OEM/ODM supplement manufacturer serving EU-bound brands, understanding EFSA health claims is not optional — it is a business survival skill. Products with non-compliant labels get detained at EU borders, recalled, or face financial penalties. This guide breaks down exactly what EFSA health claims require and how your manufacturing partner can help your clients stay on the right side of the regulation.

What EFSA Actually Regulates

The EU food supplement sector operates under Directive 2002/46/EC, which sets minimum harmonization rules across all 27 member states. But the real teeth of the regulation comes from Regulation (EC) No 1924/2006 — the Nutrition and Health Claims Regulation (NHCR).

Under this framework, two categories of claims are permitted on food and supplement products sold in the EU:

Nutrient Content Claims describe the presence or absence of a nutrient (e.g., “high in vitamin C,” “low fat,” “source of fiber”). These follow specific conditions of use defined in the regulation’s Annexes.

Health Claims describe a relationship between a food or ingredient and health. These require authorization from the European Commission based on EFSA scientific assessment before they can be used on product labels or in marketing.

Unauthorized health claims are prohibited — period. Even seemingly harmless statements like “supports immune function” or “good for your bones” can be considered unauthorized health claims in the EU context.

The Article 13 vs. Article 13.5 vs. Article 14 Distinction

Understanding which category a health claim falls into determines everything:

Article 13 (General Function Claims): These are generic health claims about the role of a nutrient or substance in growth, development, or bodily functions (e.g., “Calcium contributes to normal muscle function”). EFSA maintains a Positive List of approved Article 13 claims. A claim must appear on this list — exactly as worded — to be legally used.

Article 13.5 (Claims Based on New Scientific Evidence): If a manufacturer has proprietary studies supporting a health claim not on the Article 13 list, they can submit an application for authorization. This is expensive, time-consuming, and rarely practical for small-to-medium supplement brands.

Article 14 (Reduction of Disease Risk Claims & Claims Referring to Children’s Development): These are stronger claims linking a product to reducing a disease risk or benefiting children’s development. They require full EFSA authorization and are the highest regulatory bar.

For most Chinese OEM manufacturers, the practical takeaway is simple: only use claims that appear exactly as written on EFSA’s Article 13 Positive List, or advise clients to engage EU regulatory consultants before adding any non-standard wording to labels.

The Positive List: Your Most Important Reference Tool

EFSA published its first Article 13 health claims Positive List in 2012, covering approximately 200+ approved claims for foods and food constituents. The list includes authorized wording, specific conditions of use, and in some cases restrictions.

Key examples relevant to the supplement industry:

• Vitamin D — “contributes to the normal function of the immune system” / “contributes to the maintenance of normal muscle function”
• Magnesium — “contributes to a reduction of tiredness and fatigue” / “contributes to electrolyte balance”
• Omega-3 (EPA/DHA) — “EPA and DHA contribute to the normal function of the heart” (with specific daily intake conditions)
• Vitamin C — “contributes to the normal function of the immune system” / “contributes to collagen formation”

Each approved claim has specific conditions of use — minimum amounts, required labeling statements, and in some cases maximum levels. Manufacturers must ensure formulations meet these conditions before applying approved claims to product labels.

The critical compliance risk: if your client’s product does not meet the conditions of use for a listed claim, you cannot use that claim even if it appears on the EFSA Positive List.

What You Must NOT Say on EU Labels

This is where many Chinese manufacturers unintentionally create compliance risks for their clients:

Structure-Function Language That Sounds Like Disease Claims: Statements like “reduces cholesterol,” “supports liver detox,” or “prevents heart disease” are disease risk reduction claims (Article 14) in the EU. These require full EC authorization and are almost never used by supplement brands in practice.

Botanical Claims Without Proper Wording: If your client’s product contains botanical ingredients (e.g., Ginkgo biloba, Valerian), the health claims authorized for those botanicals are often very limited or nonexistent on the EFSA Positive List. Be extremely cautious about any marketing language added to labels beyond generic descriptors.

“Free From” Claims: While “gluten-free” and “lactose-free” are permitted under specific conditions, the EU has strict rules about what can and cannot be claimed. Claims like “contains no additives” require substantiation.

Comparative Claims: Saying your product is “better than” or “contains more than” a competitor’s product requires specific comparative data and must follow EFSA’s format rules.

What a Compliant OEM Partner Does Differently

A manufacturing partner who understands EFSA compliance does more than produce your product — they actively prevent labeling mistakes that can cost your clients the EU market:

1. Pre-Label Review Service: Every EU-bound label should be reviewed by the factory’s regulatory team before print. The review checks each claim against EFSA’s current Positive List and verifies that formulation quantities meet all conditions of use.
2. Ingredient-Level Compliance Check: Some ingredients require maximum safe levels to be observed under EU food supplement legislation (Directive 2002/46/EC Annexes). Your OEM partner must have these limits in their formulation database.
3. Language Requirements: Labels intended for EU sale must be in the official language of the country of sale. Multi-language labels are common for brands selling across multiple EU markets.
4. Import Alert Monitoring: Chinese manufacturers that have received EU import alerts for non-compliant products face significant barriers to re-entry. A compliant manufacturer protects your client’s market access.
5. Traceability and Recall Capability: EU Food Law (Regulation 178/2002) requires full traceability of all ingredients back to their origin. A well-run OEM facility maintains complete supply chain documentation for every ingredient used.

A Practical Checklist for EU Market Entry

Before your client’s product is shipped to the EU, confirm the following:

• All health claims on labels match EFSA’s Article 13 Positive List wording exactly
• Formulation quantities meet all applicable conditions of use (minimum amounts, daily intake requirements)
• No language appears that could be interpreted as a disease risk reduction claim
• All ingredient names follow EU food supplement naming conventions
• Labels include mandatory EU-specific information (e.g., storage conditions, allergen information, country of origin)
• Third-party lab reports are available for all active ingredients
• A fully documented traceability system is in place
• Your manufacturing partner holds relevant certifications (GMP, ISO 22000, FSSC 22000 are well-regarded in EU regulatory circles)

Final Takeaway

The EU supplement market rewards brands that play by the rules. EFSA health claims compliance is not a bureaucratic burden — it is a competitive advantage. Brands that confidently display authorized health claims on their labels signal to European consumers and retailers that their products meet the highest scientific and regulatory standards.

For Chinese supplement brands entering the EU market, or for brands worldwide sourcing from Chinese manufacturers, choosing an OEM partner who genuinely understands EFSA compliance can be the difference between a smooth market entry and a costly regulatory crisis.

Ready to work with a manufacturer that understands global compliance? Contact us today:

Email: Wade@zuoningbio.com
Phone: +86 187 5469 6289
Website: www.zuoningbio.com

Dongying Zuoning Biotechnology Co., Ltd. — Your trusted OEM/ODM partner for global supplement manufacturing.